Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2018 2
2019 12
2020 30
2021 10
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects.
Quetglas-Llabrés MM, Quispe C, Herrera-Bravo J, Catarino MD, Pereira OR, Cardoso SM, Dua K, Chellappan DK, Pabreja K, Satija S, Mehta M, Sureda A, Martorell M, Satmbekova D, Yeskaliyeva B, Sharifi-Rad J, Rasool N, Butnariu M, Bagiu IC, Bagiu RV, Calina D, Cho WC. Quetglas-Llabrés MM, et al. Among authors: satija s. Oxid Med Cell Longev. 2022 Apr 25;2022:8615242. doi: 10.1155/2022/8615242. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35509838 Free PMC article. Retracted. Review.
Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.
Gull N, Arshad F, Naikoo GA, Hassan IU, Pedram MZ, Ahmad A, Aljabali AAA, Mishra V, Satija S, Charbe N, Negi P, Goyal R, Serrano-Aroca Á, Al Zoubi MS, El-Tanani M, Tambuwala MM. Gull N, et al. Among authors: satija s. J Gastrointest Cancer. 2023 Jun;54(2):368-390. doi: 10.1007/s12029-022-00809-z. Epub 2022 Mar 14. J Gastrointest Cancer. 2023. PMID: 35285010 Free PMC article. Review.
Gene Therapy for Neuropsychiatric Disorders: Potential Targets and Tools.
Shahcheraghi SH, Ayatollahi J, Lotfi M, Aljabali AAA, Al-Zoubi MS, Panda PK, Mishra V, Satija S, Charbe NB, Serrano-Aroca Á, Bahar B, Takayama K, Goyal R, Bhatia A, Almutary AG, Alnuqaydan AM, Mishra Y, Negi P, Courtney A, McCarron PA, Bakshi HA, Tambuwala MM. Shahcheraghi SH, et al. Among authors: satija s. CNS Neurol Disord Drug Targets. 2023;22(1):51-65. doi: 10.2174/1871527321666220304153719. CNS Neurol Disord Drug Targets. 2023. PMID: 35249508 Review.
61 results